Magnetization transfer imaging in 'premanifest' Huntington's disease

Area of Science:

• Neuroimaging
• Genetics
• Neurology

Background:

• Huntington's disease (HD) is a progressive neurodegenerative disorder.
• Early detection of brain changes in premanifest HD gene carriers is crucial for understanding disease progression.
• Magnetization transfer imaging (MTI) is a magnetic resonance imaging (MRI) technique that probes tissue microstructure.

Purpose of the Study:

• To evaluate MTI as a tool for detecting diffuse brain abnormalities in premanifest HD gene carriers.
• To explore the relationship between MTI measures, clinical assessments, and CAG repeat length in HD.
• To assess the potential of MTI in monitoring disease progression and heterogeneity.

Main Methods:

• Sixteen premanifest HD gene carriers and 14 non-carriers underwent clinical evaluation and MRI scans.
• MTI analysis was performed on whole brain, grey matter, and white matter, generating magnetization transfer ratio (MTR) histograms.
• Statistical analyses examined associations between MTR histogram parameters, clinical measures (UHDRS motor abnormalities), and CAG repeat length.

Main Results:

• A lower peak height in the grey matter MTR histogram was significantly associated with increased UHDRS motor abnormalities in carriers.
• Lower peak heights across whole brain, grey matter, and white matter MTR histograms strongly correlated with longer CAG repeat lengths.
• No significant differences in MTI measures were found between premanifest HD carriers and non-carriers.

Conclusions:

• While MTI did not reveal significant differences between premanifest carriers and non-carriers, MTR histogram peak height may reflect subclinical disease burden.
• Lower MTR peak height in premanifest HD carriers is linked to subtle motor abnormalities and higher CAG repeat length.
• MTI shows potential for monitoring disease progression and understanding clinical heterogeneity in Huntington's disease.